Phase 1 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Trial Profile

Phase 1 trial of Sinovac's Sabin-inactivated poliovirus vaccine in China

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Oct 2016

At a glance

  • Drugs Poliovirus vaccine Intravacc/WHO (Primary)
  • Indications Poliomyelitis
  • Focus Adverse reactions
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 19 Oct 2016 Status changed from not yet recruiting to recruiting, according to Sinovac Biotech media release.
    • 23 Aug 2016 Planned initiation date changed from 1 Jan 2016 to 1 Sep 2016, as reported in a Sinovac Biotech media release.
    • 10 Dec 2015 According to a Sinovac media release, the China Food and Drug Administration (CFDA) has given approval to start human clinical trials on Sabin Inactivated Polio Vaccine in China. The Company plans to start the clinical trial in the first half of 2016 and expects to complete these trials by 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top